THE EFFECTS OF AROMATIC AND ALIPHATIC MALEIMIDE CROSSLINKERS ON ANTI-CD5 RICIN IMMUNOTOXINS

被引：15
作者：
MYERS, DE
UCKUN, FM
SWAIM, SE
VALLERA, DA
机构：
[1] UNIV MINNESOTA HOSP & CLIN,DEPT THERAPEUT RADIOL,BOX 367,HARVARD ST & E RIVER RD,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA HOSP & CLIN,EXPTL CANC IMMUNOL SECT,MINNEAPOLIS,MN 55455
来源：
JOURNAL OF IMMUNOLOGICAL METHODS | 1989年 / 121卷 / 01期
关键词：
D O I：
10.1016/0022-1759(89)90428-6
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：129 / 142
页数：14
相关论文
共 50 条
  • [31] INVIVO TREATMENT WITH ANTI-CD8 AND ANTI-CD5 MONOCLONAL-ANTIBODIES ALTERS INDUCED TOLERANCE TO ADJUVANT ARTHRITIS
    LARSSON, P
    HOLMDAHL, R
    KLARESKOG, L
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1989, 40 (01) : 49 - 56
  • [32] Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients
    Przepiorka, D
    Chan, KW
    Champlin, RE
    Culbert, SJ
    Petropoulos, D
    Ippoliti, C
    Khouri, I
    Huh, YO
    Vreisendorp, H
    Deisseroth, AB
    Bleyer, WA
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 737 - 741
  • [33] Pretreatment of kidney allografts with anti-CD5 immunotoxin: A new chance for high responder recipients
    Alexeev, LP
    Toptygin, AY
    Korenkova, EV
    Moisiuk, YG
    Muromtseva, IB
    Tonevitsky, AG
    Dolbin, AG
    Sechkin, AV
    Shumakov, VI
    Vasilov, RG
    Khaitov, RM
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) : 3605 - 3606
  • [34] DIFFERENTIAL PATTERNS OF RESPONSE TO TREATMENT WITH AN ANTI-CD5 IMMUNOCONJUGATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    STRAND, V
    LEE, M
    CANNON, G
    OLSEN, N
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S105 - S105
  • [35] An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis
    Ikezumi, Y
    Kawachi, H
    Toyabe, S
    Uchiyama, M
    Shimizu, F
    KIDNEY INTERNATIONAL, 2000, 58 (01) : 100 - 114
  • [36] EFFECTS OF ADMINISTRATION OF AN ANTI-CD5 PLUS IMMUNOCONJUGATE IN RHEUMATOID-ARTHRITIS - RESULTS OF 2 PHASE-II STUDIES
    STRAND, V
    LIPSKY, PE
    CANNON, GW
    CALABRESE, LH
    WIESENHUTTER, C
    COHEN, SB
    OLSEN, NJ
    LEE, ML
    LORENZ, TJ
    NELSON, B
    CUSH, JJ
    WOLFE, F
    FLEISCHMANN, RM
    KARR, RM
    KRICK, GH
    MEDSGER, TA
    RIGBY, WFC
    FOX, DA
    SWARTZ, TJ
    MULTZ, CV
    WEISMAN, MH
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : 620 - 630
  • [37] CYTO-TOXIC EFFECTS OF ANTI-CD5 RADIOIMMUNOTOXINS ON HUMAN-TUMORS INVITRO AND IN A NUDE-MOUSE MODEL
    MANSKE, JM
    BUCHSBAUM, DJ
    HANNA, DE
    VALLERA, DA
    CANCER RESEARCH, 1988, 48 (24) : 7107 - 7114
  • [38] Senza5 TM CART5: An Autologous CD5-Deleted Anti-CD5 CART Product with Enhanced Anti-T-Cell Lymphoma Activity
    Snook, Adam E.
    Patel, Ruchi P.
    Ghilardi, Guido
    Nimmagadda, Aditya
    Yang, Steven
    Qian, Dean
    Porazzi, Patrizia
    Mazanet, Rosemary
    Schuster, Stephen J.
    Barta, Stefan K.
    Trang Vu
    Ruella, Marco
    Siciliano, Nicholas A.
    BLOOD, 2023, 142
  • [39] INVITRO AND INVIVO PROPERTIES OF AN ANTI-CD5 - MOMORDIN IMMUNOTOXIN ON NORMAL AND NEOPLASTIC T-LYMPHOCYTES
    PORRO, G
    BOLOGNESI, A
    CARETTO, P
    GROMO, G
    LENTO, P
    MISTZA, G
    SCIUMBATA, T
    STIRPE, F
    MODENA, D
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (05) : 346 - 350
  • [40] CLINICAL DEVELOPMENT OF A NOVEL CD5 KNOCKED OUT ANTI-CD5 CAR T CELL PRODUCT FOR T CELL LYMPHOMA
    Patel, R.
    Ghilardi, G.
    Porazzi, P.
    Yang, S.
    Qian, D.
    Zhang, Y.
    Pajarillo, R.
    Schuster, S.
    Barta, S.
    Nimmagadda, A.
    Snook, A.
    Siciliano, N.
    Ruella, M.
    CYTOTHERAPY, 2023, 25 (06) : S248 - S248
12345